DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Biologics Market

Global Biologics Market Opportunities and Forecast 2020-2027

  • DLR2516
  • 13 August, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Biologics Market, By Product (Monoclonal Antibodies, Vaccines, Cell Therapy, Recombinant Hormones/Proteins, Gene Therapy), By Application (Infectious Diseases, Oncology, Immunology, Autoimmune Diseases), and opportunities and forecast 2020-2027

Biologics Market Overview

Biologics are a special type of powerful drug that slows or stops damaging inflammation. The global biologics market is anticipated to grow significantly over the forecast period. The major factors such as sizable investments in research and developmental activities in the biotechnology and pharmaceutical sector and the increasing demand for novel therapies for several rare diseases are boosting the growth of the global biologics market progressively.

Furthermore, recent researches in new therapies and combination therapies have formed the efficiency of biologics for treating a wide range of chronic diseases such as cancer, rheumatoid arthritis, macular degeneration. In addition to this, recombinant DNA technology has been expanding the potential of the biologics market. Moreover, increasing approval of biologics by several regulatory agencies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) further largely supporting the growth of the global Biologics market.

Covid-19 Impact on Biologics Market

In addition, the current Biologics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Biologics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Biologics Market Segment Overview

According to Product, the Monoclonal Antibodies segment is projected to lead the global Biologics market over the forecast period. The growth of this segment is primarily attributed to the growing demand for personalized therapies in several regions. Additionally, widespread researches in antibodies to discover targeted therapies for various diseases, such as different types of cancers, infections, and many immunological disorders, are anticipated to fuel the growth of the market. As well, the Vaccines segment is projected to show the fastest growth in the forthcoming years due to its usage as a preventative tool in infectious diseases. Based on Application, the Oncology segment is accounted for the maximum share of the market. This is due to the growing prevalence of cancer coupled with the presence of different R&D projects. These projects contain gene therapies and antisense therapies for cancer abolition.

Biologics Market, By Product

·       Monoclonal Antibodies
·       Vaccines
·       Cell Therapy
·       Recombinant Hormones/Proteins
·       Gene Therapy

Biologics Market, By Application

·       Infectious Diseases
·       Oncology
·       Immunology
·       Autoimmune Diseases

Biologics Market Regional Overview

In terms of geography, North America is projected to occupy the largest revenue share of the global Biologics market over the forecast period. The intensive R&D activities, advanced drug formulations, and growing clinical trials focused on large-molecule drug discovery are some favorable factors that extend the market’s growth in this region. Likewise, Europe is the second significant region for Biologics. On the other hand, the market in the Asia Pacific is expected to witness remarkable growth in the coming period.  An extensive patient base in need of novel therapies for chronic diseases and the low cost involved in drug manufacturing are major factors that boosting the growth of the market in the Asia Pacific region. Additionally, the global pharmaceutical companies setting up their biologics production facilities in emerging markets, mainly China, is likely to boost the regional market.

Biologics Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Biologics Market Competitor overview

Some key developments and strategies adopted by manufacturers in Biologics are highlighted below.

·       In August 2021, Evotec SE announced the opening of its J.POD 1 late-stage clinical and commercial biologics biomanufacturing facility, in Redmond, Wash., part of Just - Evotec Biologics' J.DESIGN platform, which integrates data analytics and machine learning for the discovery, development, and manufacturing of biologic drugs.

·       In August 2021, AGC Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that it has finalized the acquisition of a commercial manufacturing facility in Longmont, Colo., previously owned by Novartis Gene Therapies. The facility significantly expands AGC Biologics’ capacity for producing cell and gene therapies, with additional space to expand.

Biologics Market, Key Players

·       AbbVie Inc.
·       AstraZeneca
·       Amgen Inc.
·       F. Hoffmann-La Roche Ltd
·       Bayer AG
·       Sanofi
·       Eli Lilly and Company
·       GlaxoSmithKline Plc.
·       Pfizer Inc.
·       Merck & Co., Inc.
·       Novartis AG

Biologics Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Biologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Product
        • 5.2.1. Monoclonal Antibodies
        • 5.2.2. Vaccines
        • 5.2.3. Cell Therapy
        • 5.2.4. Recombinant Hormones/Proteins
        • 5.2.5. Gene Therapy
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Infectious Diseases
        • 5.3.2. Oncology
        • 5.3.3. Immunology
        • 5.3.4. Autoimmune Diseases
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East and Africa

      6. North America Biologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Product
        • 6.2.1. Monoclonal Antibodies
        • 6.2.2. Vaccines
        • 6.2.3. Cell Therapy
        • 6.2.4. Recombinant Hormones/Proteins
        • 6.2.5. Gene Therapy
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Infectious Diseases
        • 6.3.2. Oncology
        • 6.3.3. Immunology
        • 6.3.4. Autoimmune Diseases
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe Biologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Product
        • 7.2.1. Monoclonal Antibodies
        • 7.2.2. Vaccines
        • 7.2.3. Cell Therapy
        • 7.2.4. Recombinant Hormones/Proteins
        • 7.2.5. Gene Therapy
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Infectious Diseases
        • 7.3.2. Oncology
        • 7.3.3. Immunology
        • 7.3.4. Autoimmune Diseases
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific Biologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Product
        • 8.2.1. Monoclonal Antibodies
        • 8.2.2. Vaccines
        • 8.2.3. Cell Therapy
        • 8.2.4. Recombinant Hormones/Proteins
        • 8.2.5. Gene Therapy
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Infectious Diseases
        • 8.3.2. Oncology
        • 8.3.3. Immunology
        • 8.3.4. Autoimmune Diseases
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Biologics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Product
        • 9.2.1. Monoclonal Antibodies
        • 9.2.2. Vaccines
        • 9.2.3. Cell Therapy
        • 9.2.4. Recombinant Hormones/Proteins
        • 9.2.5. Gene Therapy
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Infectious Diseases
        • 9.3.2. Oncology
        • 9.3.3. Immunology
        • 9.3.4. Autoimmune Diseases
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. AbbVie Inc.
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. AstraZeneca
      • 10.6. Amgen Inc.
      • 10.7. F. Hoffmann-La Roche Ltd
      • 10.8. Bayer AG
      • 10.9. Sanofi
      • 10.10. Eli Lilly and Company
      • 10.11. GlaxoSmithKline Plc.
      • 10.12. Pfizer Inc.
      • 10.13. Merck & Co., Inc.
      List of Figures

      Figure 1: Global Biologics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Biologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Biologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Biologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Biologics Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Biologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Biologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Biologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Biologics Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Biologics Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Biologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Biologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Biologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Biologics Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Biologics Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Biologics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Biologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Biologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Biologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Biologics Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Biologics Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Biologics Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Biologics Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Biologics Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Biologics Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Biologics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Biologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Biologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Biologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Biologics Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Biologics Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Biologics Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Biologics Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Biologics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Biologics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Biologics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Biologics Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Biologics Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Biologics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Biologics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Biologics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Biologics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Biologics Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Biologics Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Biologics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Biologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Biologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Biologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Biologics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Biologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Biologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Biologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Biologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Biologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Biologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Biologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Biologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Biologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Biologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Biologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Biologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Biologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Biologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Biologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Biologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Biologics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Biologics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Biologics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Biologics Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934